Fruiting Body vs. Mycelium
44 mg/100g DW
Controlled liquid-culture mycelium can contain up to 44 mg of ergothioneine per 100g dry weight — exceeding typical fruiting body content and illustrating why high-quality mycelium and fruiting body extracts can offer genuinely different nutritional profiles.
Fijałkowska et al., Int J Med Mushrooms, 2021
0 regulations
define what 'full spectrum' means on a supplement label
Opposite effects
fruiting body and mycelium of same species showed opposite IL-1β responses (Lin 2019)
Mycelium-only
Lion's Mane erinacines exist exclusively in mycelium — not in the fruiting body
Fijałkowska et al., Int J Med Mushrooms, 2021
View as image ↗"Full spectrum" appears on mushroom supplement labels with increasing frequency. The implied promise is that you're getting the complete biological picture of a species — both fruiting body and mycelium included. The problem: no regulatory body defines what "full spectrum" means, no testing standard verifies it, and any product can use the term regardless of what it actually contains.
There is, however, a genuine scientific case for why combining fruiting body and mycelium can matter. It's species-specific, compound-specific, and depends heavily on how the mycelium was produced. This article examines what the research actually supports. For the broader comparison of how fruiting body and mycelium differ as supplement forms, see Fruiting Body vs. Mycelium: The Great Mushroom Supplement Debate.
Key Takeaways
- "Full spectrum" has no regulatory definition in the US or EU; any product can use the term without meeting any standard for content or extraction method.
- The scientific case for combining fruiting body and mycelium rests on species-specific compound distribution: Lion's Mane erinacines are exclusively produced in mycelium, while hericenones are concentrated in the fruiting body — a species where both forms provide unique compounds.
- A 2019 direct comparison found that fruiting body extract and solid-state mycelium of the same mushroom species (Taiwanofungus camphoratus) produced opposite effects on IL-1β — one upregulated the inflammatory marker under stress, the other downregulated it. (Lin et al., Nutrients, 2019)
- Dual extraction (hot water + ethanol in sequence) is chemically necessary to capture both water-soluble beta-glucan polysaccharides and ethanol-soluble triterpenoids and phenolics. Simply mixing two dried powders is not dual extraction.
- Controlled liquid-culture mycelium can produce higher concentrations of ergothioneine (up to 44.31 mg/100g dry weight) and tocopherols than typical fruiting bodies, but grain-based mycelium products are a different category with lower bioactive content.
- Clinical immune evidence for medicinal mushrooms — including the five most studied species — is primarily from fruiting body extracts or standardized whole-mushroom extracts, not from grain-grown mycelium biomass. (Guggenheim et al., Integrative Medicine, 2014)
"Full Spectrum" Is a Marketing Term, Not a Standard
In the US, mushroom supplements are regulated as dietary supplements under DSHEA, which does not require pre-market testing or define terms like "full spectrum," "whole mushroom," or "dual extract." A company can label a product "full spectrum" whether it contains 90% fruiting body extract, 90% grain-grown mycelium, or an equal blend of both, with no legal requirement to specify.
This matters because the term implies comprehensiveness. In botanical and supplement marketing, "full spectrum" typically signals that the product retains all the active compounds of the source material rather than isolating one fraction. But in the mushroom supplement space, it has been applied to a range of products with very different chemistry.
A 2022 comparison of metabolites across mycelium and fruiting bodies found that substrate chemistry, strain selection, and developmental stage all produced wide variation in compound content — making "full spectrum" claims that don't specify these variables essentially unverifiable by a consumer reading a label.[1] The term is more useful as a question to ask about a product than as a claim to trust on a label.
When Combining the Two Forms Actually Makes Scientific Sense
Despite the marketing ambiguity, there is a legitimate scientific argument for combining fruiting body and mycelium extracts. It is not that one form is "better" in general terms. It is that, for certain species, the two forms contain different compounds with different biological activities.
The most direct evidence comes from a 2019 study by Lin and colleagues, which directly compared fruiting body extract and solid-state-cultivated mycelium of Taiwanofungus camphoratus (a Taiwanese medicinal polypore) in the same experimental conditions.[2] The result was not that one was stronger than the other. The fruiting body extract increased interleukin-1 beta (a signaling molecule that activates inflammation) under inflammatory conditions. The mycelium extract downregulated the same marker.
Interleukin-1 beta is part of the body's inflammatory cascade. When it needs to be activated, you want it to go up. When inflammation needs to be resolved, you want it to go down. The fruiting body and mycelium of the same species pushed in opposite directions on this single marker.
This finding does not establish that combining the two forms is always better — it establishes that they are genuinely different products, not just different doses of the same compounds. A comprehensive 2021 review of edible mushrooms and beta-glucans confirms that clinical evidence for immune effects exists primarily for fruiting body extracts or purified beta-glucans, while whole myceliated grain biomass has limited clinical backing.[6] The Lin finding suggests that for species where both forms have distinct activities, combining them could offer a broader biological profile than either alone. Whether that profile is additive or complementary is an open question.
The Species-Specific Case: Compounds That Exist in Only One Form
The strongest argument for full-spectrum products comes from species where specific compounds are found exclusively in one form. Lion's Mane (Hericium erinaceus) is the clearest example.
Lion's Mane produces two classes of bioactive compounds relevant to neurological support. Hericenones are found in the fruiting body. Erinacines are found exclusively in the mycelium.[3] They are structurally different molecules with different mechanisms. Erinacines cross the blood-brain barrier, where hericenones appear not to.
In 2016, Tsai-Teng and colleagues tested erinacine A-enriched Lion's Mane mycelium in an Alzheimer's disease mouse model.[3] The mycelium preparation reduced amyloid plaques and tau tangles. The critical detail: erinacines cannot be obtained from fruiting body products. A Lion's Mane supplement made exclusively from fruiting body extract — regardless of quality — does not contain erinacines.
This makes Lion's Mane the strongest species-level case for a genuinely full-spectrum product. A product containing high-quality fruiting body extract (for hericenones) combined with quality mycelium extract (for erinacines) offers a compound profile that neither form alone can provide.
Turkey Tail (Trametes versicolor) offers another example. The polysaccharide-peptide (PSP) associated with immune effects in human trials is concentrated in mycelium preparations, while krestin (PSK), the compound used in Japanese pharmaceutical applications, is derived from the fruiting body. A full-spectrum Turkey Tail product captures both compound classes.
The ergothioneine finding: A 2021 study by Fijałkowska and colleagues measured ergothioneine content in controlled liquid-culture mycelium of Fomitopsis officinalis and found concentrations up to 44.31 mg/100g dry weight — a level exceeding typical fruiting body content for many species.[4] Ergothioneine is an amino acid with antioxidant and cytoprotective properties. The study also found tocopherol (vitamin E) up to 69.00 mg/100g dry weight in the controlled mycelium preparation. This is not an argument that grain-grown mycelium is superior. It is an argument that quality-controlled liquid-culture mycelium, produced under optimized conditions, can contain meaningful concentrations of compounds the fruiting body does not concentrate as highly.
For a deeper look at compound-by-compound distribution across the fungal lifecycle, see Mycelium vs. Fruiting Body vs. Spore: Where Do the Bioactives Actually Live?.
Why Dual Extraction Is Chemistry, Not Just Branding
The extraction method used to produce a full-spectrum supplement determines which compounds actually end up in the final product. Combining two poorly extracted powders is not a full-spectrum product.
A 2021 study by Fogarasi and colleagues compared hot-water, ethanol, and mixed solvent extraction across fruiting bodies and measured the resulting antioxidant and polyphenolic profiles.[7] The finding: hot water extraction preferentially captured polysaccharides (including beta-glucans), while ethanol extraction captured phenolic compounds and other lipophilic constituents. Neither solvent alone captured the full compound profile of the mushroom material.
This is why dual extraction — sequential extraction first with hot water, then with ethanol — is the appropriate method for a product that genuinely aims to capture both compound classes. Polysaccharides (including the beta-glucans responsible for immune priming) are water-soluble and extracted efficiently with hot water. Triterpenoids, phenolics, and lipophilic compounds like ergosterol are not water-soluble and require an alcohol extraction step.
A product that lists "dual extract" but uses only one solvent, or that mixes a hot-water extract powder with an unextracted mycelium-on-grain powder, is not applying dual extraction as the chemistry defines it. For a detailed treatment of what extraction methods produce and how to read supplement labels for them, the cluster article on dual extraction covers this in depth.
The Mycelium Quality Problem: Not All Mycelium Is Created Equal
The argument for full-spectrum products assumes that the mycelium component contains meaningful concentrations of the target compounds. This assumption fails when the mycelium was produced by colonizing grain and then drying the whole grain-plus-mycelium mass.
The structural problem with grain-grown mycelium products is that the grain substrate cannot be separated from the mycelium, so the final product contains a large proportion of grain starch. Real-world testing of supplements using grain-based mycelium production found alpha-glucan (starch) content of 33-68% in fermented grain products, compared to near-zero in authentic mushroom canker material.[1] A "full spectrum" product in which the mycelium component is predominantly grain starch is not providing the compounds the label implies.
The Fijałkowska 2021 findings on controlled liquid-culture mycelium are not about grain-grown mycelium. Liquid-fermented mycelium is grown in a nutrient broth without a grain substrate, allowing the mycelium to be separated from the growth medium before processing. This is a different production method that yields a different compound profile.
The practical implication: when evaluating a full-spectrum product, the relevant question is not whether mycelium is listed as an ingredient, but how that mycelium was produced. Liquid-fermented or "standardized mycelium extract" language suggests a higher-quality process than "mycelium on grain" or "myceliated grain."
For the full picture on why grain-based mycelium is controversial and how to identify it on a label, see Mycelium on Grain: Why It's Controversial in the Supplement Industry.
What the Clinical Evidence Base Actually Covers
The clinical evidence for medicinal mushrooms, where it exists, is primarily from studies using fruiting body extracts or standardized preparations — not from grain-grown mycelium biomass.
A 2014 systematic review by Guggenheim and colleagues evaluated the clinical immune modulation evidence for five major mushrooms: Agaricus blazei, Cordyceps sinensis, Grifola frondosa (Maitake), Ganoderma lucidum (Reishi), and Trametes versicolor (Turkey Tail).[5] The clinical backing for immune effects in all five species was based on fruiting body extracts or standardized mycelium extracts (not grain biomass). For the species in this group with the strongest clinical evidence, Turkey Tail and Reishi, the trials used hot-water fruiting body extracts or concentrated polysaccharide preparations.
This does not mean mycelium has no role. It means that when evaluating a full-spectrum product's claimed clinical backing, you need to check what form of the mushroom was actually tested in the trials the brand is citing. "Studies show mushroom X supports immunity" may be true for a hot-water fruiting body extract and untested for the grain-based mycelium in the same brand's capsule.
How to Evaluate a Full-Spectrum Product
Based on the research, a genuinely full-spectrum mushroom supplement should meet several criteria that can be verified on the label or by contacting the manufacturer.
Separate identification of both components: The label should list fruiting body extract and mycelium extract as separate ingredients, with different extraction specifications. If only "full spectrum mushroom blend" appears without breaking down the components, the ratio and quality of each are unknown.
Beta-glucan percentage listed separately from total polysaccharides: Total polysaccharide content measurements include both beta-glucans (immune-active) and alpha-glucans (starches, no known immune benefit). A beta-glucan percentage measured by a specific method (such as the Megazyme enzymatic assay) is the relevant number. For species with meaningful fruiting body beta-glucan content, 20% or higher beta-glucan is typical in quality fruiting body extracts.
Extraction method specified: Hot-water extraction for beta-glucans; ethanol or alcohol extraction for triterpenoids and phenolics; dual extraction for both. A product that lists extraction method and solvent demonstrates transparency about how compounds were captured.
Mycelium production method: Liquid-fermented mycelium or "standardized mycelium extract" versus "mycelium on grain." For the full-spectrum claim to hold for bioactive compounds specific to mycelium, the mycelium component should come from a production process that separates mycelium from any grain substrate.
Species-specific justification: The full-spectrum argument is strongest for species like Lion's Mane where fruiting body and mycelium contain genuinely exclusive compounds. For species where the compound distribution is less differentiated between forms, the rationale for combining both is weaker.
For guidance on what to look for when choosing across mushroom supplement forms more broadly, see Do Fruiting Bodies Have More Bioactive Compounds Than Mycelium? and The Science Behind the Fruiting Body vs. Mycelium Argument.
The Bottom Line
"Full spectrum" mushroom supplements have no regulatory definition, but the underlying science shows a legitimate case for combining fruiting body and mycelium extracts for species like Lion's Mane, where erinacines (exclusively mycelium) and hericenones (fruiting body) are both biologically relevant. Lin 2019 found the two forms of the same species produced opposite effects on a key inflammatory marker, confirming they are genuinely different products rather than different doses. Whether a product delivers on the full-spectrum premise depends on how the mycelium was produced (liquid-culture vs. grain-based), what extraction method was used, and whether beta-glucan content is verified separately from total polysaccharides.
Frequently Asked Questions
Sources & References
- 1RTHM-00743·Berger, Ralf G et al. (2022). “Mycelium vs. Fruiting Bodies of Edible Fungi-A Comparison of Metabolites..” Microorganisms.Study breakdown →PubMed →↩
- 2RTHM-00572·Lin, Liang-Hung et al. (2019). “Immunomodulatory Effects of Fruiting Body Extract and Solid-State-Cultivated Mycelia of Taiwanofungus camphoratus..” Nutrients.Study breakdown →PubMed →↩
- 3RTHM-00452·Tsai-Teng, Tzeng et al. (2016). “Erinacine A-enriched Hericium erinaceus mycelium ameliorates Alzheimer's disease-related pathologies in APPswe/PS1dE9 transgenic mice..” Journal of biomedical science.Study breakdown →PubMed →↩
- 4RTHM-00684·Fijałkowska, Agata et al. (2021). “Fortified Mycelium of Fomitopsis officinalis (Agaricomycetes) as a Source of Biologically Active Substances Effective in the Prevention of Civilization Diseases..” International journal of medicinal mushrooms.Study breakdown →PubMed →↩
- 5RTHM-00323·Guggenheim, Alena G et al. (2014). “Immune Modulation From Five Major Mushrooms: Application to Integrative Oncology..” Integrative medicine (Encinitas.Study breakdown →PubMed →↩
- 6RTHM-00676·Cerletti, Chiara et al. (2021). “Edible Mushrooms and Beta-Glucans: Impact on Human Health..” Nutrients.Study breakdown →PubMed →↩
- 7RTHM-00686·Fogarasi, Melinda et al. (2021). “Comparison of Different Extraction Solvents for Characterization of Antioxidant Potential and Polyphenolic Composition in Boletus edulis and Cantharellus cibarius Mushrooms from Romania..” Molecules (Basel.Study breakdown →PubMed →↩